Topper James N

Average Profitability
30.73%
Insider Buys Quantity
34
Insider Buys Sum
$21.7M
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of Topper James N

According to the SEC Form 4 filings, Topper James N, being in a position of

  1. director at NewAmsterdam Pharma Company N.V.,
    оver the last 12 months, has bought 8429 shares for $181,224, and sold 0 shares,
    over all time since 2024-03-26, has bought 8429 shares for $181,224, and sold 0 shares.

The largest purchase of all time was on 2017-01-31 and amounted to 800000 shares of AnaptysBio, Inc. for $12M.

Biography of Topper James N

No biography is available at this moment.

2024-03-26PurchaseNewAmsterdam Pharma Company N.V.
NAMS
director
8,429
0.0099%
$21.50$181,224-15.69%
2017-01-31PurchaseAnaptysBio, Inc.
ANAB
800,000
4.6287%
$15.00$12M+58.88%
2008-03-10PurchaseAmicus Therapeutics, Inc.
FOLD
director
5,500
0.0253%
$10.28$56,538+5.21%
2008-03-06PurchaseAmicus Therapeutics, Inc.
FOLD
director
22,146
0.0989%
$10.02$221,914+4.95%
2008-03-05PurchaseAmicus Therapeutics, Inc.
FOLD
director
50,000
0.2244%
$9.76$487,914+8.3%
2008-03-04PurchaseAmicus Therapeutics, Inc.
FOLD
director
13,500
0.0589%
$9.89$133,506+3.91%
2008-03-03PurchaseAmicus Therapeutics, Inc.
FOLD
director
62,100
0.2724%
$9.74$605,014+6%
2008-02-29PurchaseAmicus Therapeutics, Inc.
FOLD
director
8,637
0.0392%
$10.03$86,595+6.7%
2008-02-28PurchaseAmicus Therapeutics, Inc.
FOLD
director
7,800
0.0334%
$10.06$78,460+0.24%
2008-02-27PurchaseAmicus Therapeutics, Inc.
FOLD
director
23,300
0.1047%
$9.88$230,255+7.03%
2008-02-26PurchaseAmicus Therapeutics, Inc.
FOLD
director
8,000
0.0344%
$9.90$79,205+2.14%
2008-02-25PurchaseAmicus Therapeutics, Inc.
FOLD
director
9,700
0.0423%
$9.74$94,432+5.53%
2008-02-22PurchaseAmicus Therapeutics, Inc.
FOLD
director
8,814
0.0391%
$9.89$87,151+5.73%
2008-02-21PurchaseAmicus Therapeutics, Inc.
FOLD
director
5,500
0.0238%
$10.06$55,317+1.11%
2008-02-20PurchaseAmicus Therapeutics, Inc.
FOLD
director
49,500
0.2204%
$9.62$476,109+8.92%
2008-02-19PurchaseAmicus Therapeutics, Inc.
FOLD
director
9,600
0.0436%
$9.93$95,340+7.58%
2008-02-15PurchaseAmicus Therapeutics, Inc.
FOLD
director
6,900
0.0306%
$10.45$72,1180%
2008-02-13PurchaseAmicus Therapeutics, Inc.
FOLD
director
12,000
0.0489%
$10.42$125,071-7.89%
2008-02-12PurchaseAmicus Therapeutics, Inc.
FOLD
director
9,400
0.0421%
$10.07$94,612+4.99%
2008-02-11PurchaseAmicus Therapeutics, Inc.
FOLD
director
5,700
0.0253%
$10.09$57,498+3.95%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.